Keratitis

Better diagnosis, treatment options key to nonresponsive bacterial keratitisNew treatment possibilities for nonresponsive bacterial keratitis are continually in development, including molecular-targeted therapy, the cautious use of topical corticosteroids, corneal crosslinking for superficial keratitis, and biologicals, Eduardo C. Alfonso, MD, reported.
Natamycin still the best bet for fungal keratitisA recent study sponsored by the National Eye Institute (NEI) of the optimal treatments for fungal keratitis showed that topical natamycin is still the mainstay of treatment. Adding oral voriconazole to the treatment regimen also may be beneficial to treat patients with Fusarium species.
EMA committee recommends cenegermin for neurotrophic keratitisA committee of the European Medicines Agency has recommended approval of cenegermin (Oxervate, Dompé) eye drops for neurotrophic keratitis.
Managing viral eye infection: What clinicians should knowThough much research is happening in the diagnosis and treatment of viral eye infections, much of it might not be readily apparent to clinicians, explains Todd P. Margolis, MD, PhD.
In vivo confocal microscopy ineffective for Fusarium and Aspergillus differentiationIt’s very hard to tell the difference between Fusarium and Aspergillus species with in vivo confocal microscopy (IVCM) of fungal keratitis, researchers say.
Why Acanthamoeba diagnosis is often challengingHaving an awareness of current best practices—such as epidemiology, risk factors, signs and symptoms, and tests—can be key to identifying and treating corneal infections.
7 strategies for fitting keratoconus patientsTry these seven strategies to improve your keratoconus contact lens fitting and offer better outcomes to your patients.
Resurgence of penicillin-susceptible isolatesWatch as Regis Kowalski, Executive Director, The Charles T. Campbell Laboratory at the University of Pittsburgh, explains how newly discovered resurgent isolates may affect clinical practice.
Improper contact lens use linked to permanent eye damage
How resistant biofilms affect keratitisWatch as Ben Wucher, researcher at University of Rochester Medical Center, summarizes his research titled, "Clinical keratitis isolates of Pseudomonas aeruginosa develop resistant biofilms."